Is Medivive legit and worth it?
Medivive is a real GLP-1 telehealth provider; we read its site and scored it 3.7/5 in our independent review (Competitive but Mixed). It is best for patients who want reliable, affordable compounded GLP-1 access from a medically credible platform without needing intensive coaching or comprehensive metabolic monitoring. Biggest plus: Brand-name options available. Watch-out: No/minimal Trustpilot reviews.
Scorecard: strongest in Access (4.7/5) and Cost & Value (4.6/5); weakest in Reputation (2.9/5) and Patient Protection (3.4/5).
Medications
Semaglutide, Tirzepatide (as listed on its site, 7 April 2026)
Monthly Cost
$147-$299 (as listed on its site, 7 April 2026)
Speed to Start
Fast
Trustpilot
Not yet rated (as recorded April 2026; not re-checked)
Prices and medications in this review are as listed on Medivive’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
About Medivive
Medivive was founded in 2022 as a primary care telehealth platform that has increasingly focused on GLP-1 medication prescribing for weight management. Unlike platforms built exclusively around weight loss, Medivive positions itself as a broader telehealth provider that includes GLP-1 services as part of its clinical offerings. This primary care foundation means patients can potentially address multiple health concerns — not just weight — through the same provider relationship, which can improve care coordination and reduce the fragmentation that often characterizes telehealth experiences.
The platform prescribes both compounded semaglutide and compounded tirzepatide, with monthly costs ranging from $147 to $299 depending on the medication, dosage, and plan selected. This pricing is competitive within the compounded GLP-1 market, falling below many brand-name providers while remaining slightly above the most budget-oriented options. Patients should understand that compounded medications, while containing the same active ingredients, are not FDA-approved finished products and are prepared by outsourcing pharmacies rather than the original manufacturers (Novo Nordisk or Eli Lilly).
The company does not have a Trustpilot presence, so independent consumer review data at scale is limited. Our editorial team found the platform’s clinical process to be standard for the telehealth GLP-1 space: an online health questionnaire, asynchronous or synchronous provider review, and medication shipped directly to the patient. The support level is moderate, with provider check-ins and messaging access but without the dedicated dietitian coaching, lab testing, or behavioral programming offered by higher-tier platforms.
One advantage of Medivive’s primary care orientation is the potential for more holistic clinical oversight. Because the providers are trained in general medicine rather than operating solely as weight loss prescribers, they may be better positioned to identify contraindications, manage medication interactions, and address comorbidities that affect weight management outcomes. This clinical breadth is subtle but meaningful — particularly for patients with complex health profiles who need a provider comfortable managing multiple conditions simultaneously.
Medivive is a competent, moderately priced compounded GLP-1 provider with the added benefit of a primary care clinical foundation. The pricing is fair for the compounded medication market. The platform does not stand out for clinical innovation or comprehensive support, but it delivers reliable GLP-1 access with solid medical oversight. Patients seeking brand-name medications, intensive coaching, or lab-integrated programs should consider higher-tier alternatives, while those wanting straightforward compounded GLP-1 access from a credible primary care platform will find Medivive a reasonable choice.
Medivive GLP-1 Medications
Screenshot of Medivive, captured by 10 April 2026
At a Glance
Medications Offered
Semaglutide, Tirzepatide (as listed on its site, 7 April 2026)
Both
Cost & Insurance
- Monthly: $147-$299 (as listed on its site, 7 April 2026)
- 6-month estimate: $882-$1,794 (as listed on its site, 7 April 2026)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Pharmacies named: Not disclosed
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Yes: Medivive says its care is bilingual, English and Spanish (its own page, read 7 October 2026) Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown, and the provider’s own page says otherwise.
What the Medivive Intake Looks Like
We walked through Medivive’s full GLP-1 intake ourselves, from the first quiz screen to the final payment page. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
The five quiz questions are entirely about goals, pace, and budget — none of them are clinical. The only safety screening is a single Yes/No umbrella over ten contraindications on the checkout page. The deeper clinical work appears to happen after payment.
/ 10
Very low. No early email gate, no phone OTP, no ID upload, no account creation before payment. You can reach the checkout page in roughly two minutes by clicking through five preference questions.
The 3 Stages
Clinical Safety Screens Performed
There are no per-condition checkboxes, no severity grading, and no follow-up questions — a single Yes answer covers all ten conditions at once.
The intake doesn’t collect a height or weight, doesn’t calculate a BMI, doesn’t include a validated PHQ-2 or PHQ-9 depression screen, doesn’t have a dedicated eating-disorder screen, doesn’t include a substance or alcohol screen, doesn’t review current medications, doesn’t run a general drug or food allergy check, doesn’t take a blood pressure reading, and doesn’t capture a comorbidity multi-select with per-condition checkboxes. Diet and exercise history are not asked at all. The clinical depth presumably happens during the post-payment clinician review rather than in the visible intake.
After the five-question quiz, the screen reads “Your Personalized Recommendation” and presents Tirzepatide as the match. The patient does not pick a medication — the flow does not offer Semaglutide, an oral option, or a “not sure” path. Payment is collected before any clinician sees the case, with the checkbox terms noting that the order is subject to clinician approval and the patient may be contacted for additional health information. Medical services are listed as provided by TrueEvo Medical Group, PLLC.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Medivive weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens mymedivive.com in a new tab.
Start your GLP-1 weight loss journey with Medivive today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
